Neurable develops patented signal-processing technology, branded Neurable AI, that translates brain signals into actionable data on focus, distraction, mental fatigue and cognitive recovery. Its newest consumer product, the MW75 Neuro LT headset, pairs with an updated mobile app to surface these insights in real time, bringing laboratory-grade BCI capabilities into a sleek, everyday form factor. The company plans to embed its platform across broader cognitive-health and human-performance markets, with near-term emphasis on gaming and e-sports where marginal improvements in concentration and reaction time can be decisive. Beyond consumer applications, Neurable supplies research-grade headsets via a partnership with human-behavior platform iMotions and is working with MeSpace on adaptive workstations. Management positions the company to lead a projected $52 billion global BCI market by 2034 through ethical, accessible brain data tools. Including the latest financing, Neurable has raised $65 million to date, providing capital for product expansion and additional device integrations.

Total raised

$56M

Funding rounds

5

Latest round

Series A

Latest activity

Dec 2025